<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02987894</url>
  </required_header>
  <id_info>
    <org_study_id>2016-02</org_study_id>
    <nct_id>NCT02987894</nct_id>
  </id_info>
  <brief_title>PRospective Observation of Aortic reGuRgitation aftEr TAVI and progreSS Over Time: PROGRESS PVL Registry</brief_title>
  <acronym>PROGRESS</acronym>
  <official_title>Prospective Observation of Aortic Regurgitation After TAVI and Progress Over Time: PROGRESS PVL Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Symetis SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this post-market registry is to collect and monitor ongoing safety and
      performance clinical data of the ACURATE neo™ Aortic Bioprosthesis, and the ACURATE TF™
      Transferral Delivery System, when used as per IFU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this post-market registry is to further evaluate the safety and
      performance of the ACURATE neo™ Aortic Bioprosthesis and the ACURATE TF™ Transferral Delivery
      System in 500 consented patients with severe aortic stenosis and treated according to the
      instructions for use (IFU).

      Examinations to evaluate the aortic valve regurgitation performed as standard of care in
      patients undergoing transcatheter aortic valve replacement will be analyzed by an external
      Core Laboratory. These examinations are limited to echocardiography and/or contrast
      aortography assessments.

      The secondary objective is to collect adverse events and evaluate them according to the
      VARC-2 consensus document.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Change in total aortic regurgitation over time.</measure>
    <time_frame>post-implantation on index procedure date, 7- days post-index procedure / discharge (whichever occurs first), 30 days post-index procedure and 12 months post-index procedure</time_frame>
    <description>total aortic regurgitation post procedure, at 7 days or discharge, 30 days and 12 months follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of all-cause mortality</measure>
    <time_frame>30 days post-index procedure</time_frame>
    <description>Incidence of all-cause mortality at 30 days post index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical events as defined per VARC-2 consensus document (VARC-2)</measure>
    <time_frame>Procedure, 7 days post-index procedure / discharge (whichever occurs first), 30 days post-index procedure and 12 months post-index procedure</time_frame>
    <description>Clinical events as defined per VARC-2 consensus document</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with procedural success according to VARC II criteria</measure>
    <time_frame>at index- Procedure</time_frame>
    <description>Procedural success is defined as
Absence of intra-procedure mortality and complications arising during implantation of the prosthetic valve such as:
inability to properly seat the valve in the annulus
need for more than one implanted aortic bioprosthesis (valve-in-valve or ectopic deployment)
surgical aortic valve replacement required to correct a severe aortic regurgitation or procedure complication The procedure can be considered as success despite the presence of residual aortic regurgitation which may be due to the anatomic configuration of the annulus or a calcific valvular annulus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with device success</measure>
    <time_frame>7-days post-index procedure or discharge (whichever occurs first)</time_frame>
    <description>Device success is defined as:
Absence of intra-procedure mortality (procedure to 24H) AND,
Correct positioning (placement in the annulus with no impairment of aortic bioprosthesis function) of a single prosthetic heart valve into the proper anatomical location AND,
Intended performance of the prosthetic heart valve:
No prosthesis-patient mismatch (EAOi &gt;0.85 cm2/m2) AND,
Mean aortic valve gradient &lt;20mmHg or peak velocity &lt; 3 m/s AND,
No moderate or severe prosthetic valve regurgitation.
In evaluating echo parameters, values at 7D/Discharge (whichever occurs first) will be used for each of the echo parameters above. If any of echo parameters is missing at 7-days or discharge, post-procedure data may be used for the missing values. If device success or failure cannot be determined due to missing of parameters listed above or un-evaluable echocardiography assessment, device success will be considered not obtainable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events assessed by VARC-2 Composite Safety</measure>
    <time_frame>30 days post-index procedure</time_frame>
    <description>VARC-2 Composite Safety at 30 days defined as:
All-cause mortality
All stroke (disabling and non-disabling)
Life-threatening bleeding
Acute kidney injury - Stage 2 or 3 (including renal replacement therapy)
Coronary artery obstruction requiring intervention
Major vascular complication
Valve-related dysfunction requiring repeat procedure (BAV, TAVI or SAVI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional improvement</measure>
    <time_frame>7 days post-index procedure or discharge (whichever occurs first), 30 days post-index procedure and 12 months post-index procedure</time_frame>
    <description>Functional improvement from baseline as per NYHA Functional Classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic function improvement from baseline</measure>
    <time_frame>7 days post-index procedure or discharge (whichever occurs first), 30 days post-index procedure and 12 months post-index procedure</time_frame>
    <description>Improvement from baseline of the hemodynamic function: effective orifice area and mean transprosthetic gradient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valve related dysfunction</measure>
    <time_frame>7 days post-index procedure or discharge (whichever occurs first), 30 days post-index procedure and 12 months post-index procedure</time_frame>
    <description>Valve related dysfunction defined as: mean aortic valve gradient ≥ 20mmHg, EOA ≤0.9-1.1 cm2, and/or DVI&lt; 0.35, and/or moderate or severe prosthetic valve regurgitation (See VARC-2 and Figure 4 from VARC manuscript)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Aortic Stenosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ACURATE neo™ Aortic Bioprosthesis</intervention_name>
    <description>TAVI, transcatheter aortic valve replacement. Transfemoral access.</description>
    <other_name>ACURATE TF™ Transfemoral Delivery System</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients eligible for transcatheter treatment of severe aortic stenosis with the
        ACURATE neo™ Aortic Bioprosthesis and ACURATE TF™ Transfemoral Delivery System according to
        the indication in the Instruction for Use.

        The ACURATE neo™ Aortic Bioprosthesis and its Delivery System are indicated for use in
        patients 75 years of age and older with severe aortic stenosis (mean aortic gradient &gt; 40
        mmHg or peak jet velocity &gt; 4.0 m/s or aortic valve area &lt; 1.0 cm2) for whom conventional
        surgical aortic valve replacement is considered high risk for mortality or who are not
        operable as determined either by a heart team consisting of a cardiologist and surgeon or
        by the following risk assessments:

        Logistic EuroSCORE &gt; 20%

        STS score &gt; 10%
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is included in the registry if eligible for transcatheter treatment of severe
             aortic stenosis with the ACURATE neo™ Aortic Bioprosthesis and ACURATE TF™
             Transfemoral Delivery System as per the Instructions for Use (Patients which are
             included but treated outside of the approved indication will be followed for safety
             reasons).

          2. Patient is willing to participate in the study, provides signed Informed Consent/Data
             Authorization Form and authorizes the sharing of data in the registry. Patient agrees
             that anonymized imaging data will be sent to and analyzed by an external Core
             Laboratory.

          3. The treating physician should ensure the subject will return for all required post
             procedure follow-up visits.

        Exclusion Criteria:

        1. Patients are excluded from the registry if they are not eligible for transcatheter
        treatment of severe aortic stenosis with the ACURATE neo™ Aortic Bioprosthesis and ACURATE
        TF™ Transfemoral Delivery System as per the Instructions For Use.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Won-Keun Kim, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff-Klinik Forschungsgesellschaft mbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Zanon</last_name>
    <email>sarah.zanon@bsci.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Petra</last_name>
    <phone>+41 79 245 71 21</phone>
    <email>julie.petra@bsci.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>London Health Sciences Centre, University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Dr Chu, Dr med</last_name>
      <email>Michael.Chu@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Dr Chu, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Paul's Hospital, Porvidence Health Care Institute</name>
      <address>
        <city>Vancouver</city>
        <zip>BC V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Pr Webb, Prof Dr med</last_name>
      <email>webb@providencehealth.bc.ca</email>
    </contact>
    <investigator>
      <last_name>John Pr Webb, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätklinikum</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shahram Dr Lotfi, Dr med</last_name>
      <email>slotfi@ukaachen.de</email>
    </contact>
    <investigator>
      <last_name>Shahram Dr Lotfi, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Thilo, Dr. med</last_name>
      <email>Christian.Thilo@klinikum-augsburg.de</email>
    </contact>
    <investigator>
      <last_name>Christian Dr Thilo, Dr. med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zentralklinik Bad Berka</name>
      <address>
        <city>Bad Berka</city>
        <zip>99437</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Dr Kuntze, Dr med</last_name>
      <email>thomas.kuntze@zentralklinik.de</email>
    </contact>
    <investigator>
      <last_name>Thomas Dr Kuntze, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz und Gefasszentrum</name>
      <address>
        <city>Bad Bevensen</city>
        <zip>29549</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Christof Dr Burgdorf, Dr med</last_name>
    </contact>
    <investigator>
      <last_name>Christof Dr Burgdof, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kerkhoff Kilnik</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Dr Von Keun, De med</last_name>
      <email>w.kim@kerckhoff-klinik.de</email>
    </contact>
    <investigator>
      <last_name>Kim Dr Von Keun, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Immanuel Hospital Bernau- Herzzentrum Brandenburg</name>
      <address>
        <city>Bernau</city>
        <zip>13321</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Dr Butter, Dr med</last_name>
      <email>c.butter@immanuel.de</email>
    </contact>
    <investigator>
      <last_name>Christian Dr Butter, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sana-Herzzentrum Cottbus GmbH</name>
      <address>
        <city>Cottbus</city>
        <zip>03048</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Dr Harnath, Dr med</last_name>
      <email>axel.harnath@sana.de</email>
    </contact>
    <investigator>
      <last_name>Axel Dr Harnath, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Johannes Hospital</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Pr Möllmann, Prof</last_name>
      <email>Helge.Moellmann@joho-dortmund.de</email>
    </contact>
    <investigator>
      <last_name>Helge Pr Möllmann, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goethe Universität</name>
      <address>
        <city>Frankfurt</city>
        <zip>60323</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Pr Fichtlscherer, Prof dr med</last_name>
      <email>fichtlscherer@em.uni-frankfurt.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Pr Fichtlscherer, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätklinikum Giessen</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Pr Nef, Prof Dr med</last_name>
      <email>holger.nef@me.com</email>
    </contact>
    <investigator>
      <last_name>Holger Pr Nef, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle</name>
      <address>
        <city>Halle</city>
        <zip>06097</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hendrick Pr Treede, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>hendrik.treede@uk-halle.de</last_name>
    </contact_backup>
    <investigator>
      <last_name>Hendrick Pr Treede, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Pr Schulze, Prof</last_name>
      <email>Christian.schulze@med.uni-jena.de</email>
    </contact>
    <investigator>
      <last_name>Christian Pr Schulze, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städisches Klinikum Karlsruhe GmbH</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Dr Schymik, Dr med</last_name>
      <email>Gerhard.Schymik@klinikum-karlsruhe.de</email>
    </contact>
    <investigator>
      <last_name>Gerard Dr Schymik, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helios Klinik Fur Herzzchirurgie Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76185</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Dr Conzelmann, Dr</last_name>
      <email>lars.conzelmann@helios-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Lars Dr Conzelmann, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Dr Rudolph, Dr med</last_name>
      <email>tanja.rudolph@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Tanja Dr Rudolph, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sana Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel pr Linke, Prof</last_name>
      <email>Axel.Linke@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Axel Pr Linke, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helmut Dr Baumgartner, Dr</last_name>
      <email>Helmut.Baumgartner@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Helmut Dr baumgartner, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Städische Kliniken</name>
      <address>
        <city>Neuss</city>
        <zip>41464</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Pr Haude, prof dr med</last_name>
      <email>mhaude@lukasneuss.de</email>
    </contact>
    <investigator>
      <last_name>Michael Pr Haude, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Anstalt öffentlichen Rechts</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elsaesser Pr Albrecht, pro de med</last_name>
      <email>elsaesser.albrecht@klinikum-oldenburg.de</email>
    </contact>
    <investigator>
      <last_name>Elsaesser Pr Albrecht, prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herz und Kreislaufzentrum</name>
      <address>
        <city>Rotenburg an der Fulda</city>
        <zip>36199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ardawan Pr Rastan, Prof dr med</last_name>
      <email>a.rastan@hkz-rotenburg.de</email>
    </contact>
    <investigator>
      <last_name>Ardawan Pr Rastan, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72016</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tobias Dr Geisler</last_name>
      <email>tobias.geisler@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Tobias Dr Geisler, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Saar, SHG-Kliniken</name>
      <address>
        <city>Völklingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fernando Dr Gatto, Dr med</last_name>
      <email>f.gatto@vk.shg-kliniken.de</email>
    </contact>
    <investigator>
      <last_name>Fernando Dr Gatto, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile di Legnano</name>
      <address>
        <city>Legnano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arnaldo Dr Poli, Dr med</last_name>
      <email>arnaldo.poli@asst-ovestmi.it</email>
    </contact>
    <investigator>
      <last_name>Arnaldo Dr Poli, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Toscana G.Monasterio, Ospedale del Cuore G.Pasquinucci</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Dr Berti, Dr med</last_name>
      <email>berti@ftgm.it</email>
    </contact>
    <investigator>
      <last_name>Sergio Dr Berti, Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical School of Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Dr Tarantini, Dr med</last_name>
      <email>giuseppe.tarantini.1@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Dr Tarantini, Dr Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital NHS</name>
      <address>
        <city>Leicester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jan pr Kovac, Prof dr med</last_name>
      <email>jan.kovac@uhl-tr.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jan Pr Kovac, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oford University Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajesh Pr Kharbanda, Prof</last_name>
      <email>Rajesh.Kharbanda@ouh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Rajesh Pr Kharbanda, Prof Dr med</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <removed_countries>
    <country>Argentina</country>
    <country>Poland</country>
    <country>Switzerland</country>
  </removed_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>December 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>TAVI</keyword>
  <keyword>Transcatheter Aortic Valve Replacement</keyword>
  <keyword>Transcatheter Aortic Valve Implant</keyword>
  <keyword>Transfemoral access</keyword>
  <keyword>Aortic valve regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

